Literature DB >> 22048626

Medical oncology: clinical value of circulating tumor cells in breast cancer.

Stefan Sleijfer1, John A Foekens.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 22048626     DOI: 10.1038/nrclinonc.2011.167

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies.

Authors:  Brian D Lehmann; Joshua A Bauer; Xi Chen; Melinda E Sanders; A Bapsi Chakravarthy; Yu Shyr; Jennifer A Pietenpol
Journal:  J Clin Invest       Date:  2011-07       Impact factor: 14.808

2.  Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.

Authors:  Bianca Mostert; Jaco Kraan; Joan Bolt-de Vries; Petra van der Spoel; Anieta M Sieuwerts; Mieke Schutte; Annemieke M Timmermans; Renée Foekens; John W M Martens; Jan-Willem Gratama; John A Foekens; Stefan Sleijfer
Journal:  Breast Cancer Res Treat       Date:  2010-04-09       Impact factor: 4.872

3.  Circulating tumor cells in immunohistochemical subtypes of metastatic breast cancer: lack of prediction in HER2-positive disease treated with targeted therapy.

Authors:  A Giordano; M Giuliano; M De Laurentiis; G Arpino; S Jackson; B C Handy; N T Ueno; E Andreopoulou; R H Alvarez; V Valero; S De Placido; G N Hortobagyi; J M Reuben; M Cristofanilli
Journal:  Ann Oncol       Date:  2011-09-28       Impact factor: 32.976

4.  Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer.

Authors:  Massimo Cristofanilli; Daniel F Hayes; G Thomas Budd; Mathew J Ellis; Alison Stopeck; James M Reuben; Gerald V Doyle; Jeri Matera; W Jeffrey Allard; M Craig Miller; Herbert A Fritsche; Gabriel N Hortobagyi; Leon W M M Terstappen
Journal:  J Clin Oncol       Date:  2005-03-01       Impact factor: 44.544

5.  mRNA and microRNA expression profiles in circulating tumor cells and primary tumors of metastatic breast cancer patients.

Authors:  Anieta M Sieuwerts; Bianca Mostert; Joan Bolt-de Vries; Dieter Peeters; Felix E de Jongh; Jacqueline M L Stouthard; Luc Y Dirix; Peter A van Dam; Anne Van Galen; Vanja de Weerd; Jaco Kraan; Petra van der Spoel; Raquel Ramírez-Moreno; Carolien H M van Deurzen; Marcel Smid; Jack X Yu; John Jiang; Yixin Wang; Jan W Gratama; Stefan Sleijfer; John A Foekens; John W M Martens
Journal:  Clin Cancer Res       Date:  2011-04-19       Impact factor: 12.531

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 7.  Circulating tumour cells in cancer patients: challenges and perspectives.

Authors:  Klaus Pantel; Catherine Alix-Panabières
Journal:  Trends Mol Med       Date:  2010-07-29       Impact factor: 11.951

8.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

Review 9.  Cancer micrometastases.

Authors:  Klaus Pantel; Catherine Alix-Panabières; Sabine Riethdorf
Journal:  Nat Rev Clin Oncol       Date:  2009-06       Impact factor: 66.675

10.  Anti-epithelial cell adhesion molecule antibodies and the detection of circulating normal-like breast tumor cells.

Authors:  Anieta M Sieuwerts; Jaco Kraan; Joan Bolt; Petra van der Spoel; Fons Elstrodt; Mieke Schutte; John W M Martens; Jan-Willem Gratama; Stefan Sleijfer; John A Foekens
Journal:  J Natl Cancer Inst       Date:  2008-12-30       Impact factor: 13.506

  10 in total
  4 in total

1.  Biomarkers: Where to Go from Here.

Authors:  Angelo Paradiso
Journal:  Breast Care (Basel)       Date:  2012-02-23       Impact factor: 2.860

2.  Detection and quantitation of circulating tumor cell dynamics by bioluminescence imaging in an orthotopic mammary carcinoma model.

Authors:  Laura Sarah Sasportas; Sharon Seiko Hori; Guillem Pratx; Sanjiv Sam Gambhir
Journal:  PLoS One       Date:  2014-09-04       Impact factor: 3.240

3.  Dynamic Fluctuation of Circulating Tumor Cells during Cancer Progression.

Authors:  Mazen A Juratli; Mustafa Sarimollaoglu; Dmitry A Nedosekin; Alexander V Melerzanov; Vladimir P Zharov; Ekaterina I Galanzha
Journal:  Cancers (Basel)       Date:  2014-01-15       Impact factor: 6.639

4.  Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.

Authors:  Antonia Patsialou; Yarong Wang; Juan Lin; Kathleen Whitney; Sumanta Goswami; Paraic A Kenny; John S Condeelis
Journal:  Breast Cancer Res       Date:  2012-10-31       Impact factor: 6.466

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.